Health Canada
Symbol of the Government of Canada

Common menu bar links

About Health Canada

Access to Information Requests Completed - June 2015

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

For the month of June 2015
Request # Summary of Requests Status of Completed Request Number of Pages Disclosed
A-2013-00102 Documents concerning the April 3, 2013 visit of two Health Canada employees from the Health Products and Food Branch, Inspectorate Division, to Marchese Hospital Solution, Mississauga, Ontario (possibly known as Marchese Health Care or Mezentco Solutions or Mezentco Solutions Inc.) Disclosed in part 141
A-2013-01075 All correspondence between the Health Minister, Deputy Minister and/or Health Canada and any U.S government official or agency involving Oxycontin, Oxycodone or OxyNEO and any related chemical variants. (Aug. 1, 2013 to Dec. 6, 2013) All exempted 0
A-2013-01125 A-2013-01125 Documents related to the draft versions of the Auditor General’s food recall audit. (Jan. 1, 2013 to Oct. 31, 2013) All disclosed 82
A-2014-00983 Adverse Reaction Report (AER) for Demerol (pethidine hydrochloride). Report number: 000535093. Disclosed in part 36
A-2014-01110 All contracts processed in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Task and Solutions Professional Services (TSPS) and for Task-Based Informatics Professional Services (TBIPS) during the months of January 2014 to February 2014, and August 2014 to December 2014. Disclosed in part 1,448
A-2014-01153 Documents related to the work done up to December 2014 to approve the irradiation of ground beef in Canada Disclosed in part 35
A-2014-01445 All communications of Environmental and Radiation Health Sciences Directorate within Health Environments and Consumer Safety Branch regarding the production, creation and approvals of Health Canada Fact Sheet on Safety Code 6 (2014-023) 2014. (Dec. 1, 2013 to Jan. 22, 2015) Disclosed in part 76
A-2014-01447 Documents related to Health Canada’s decision to create and subsequently remove a ban on citronella in bug spray (Jan. 1, 2013 to Feb. 28, 2015) Disclosed in part 33
A-2014-01467 Information regarding Optison, Drug Identification Number (DIN) 02239574 by Tyco Healthcare and discontinued July 9, 2003. All disclosed 391
A-2014-01482 Adverse Reaction Report (AER) for:
Yasmin, from January 1, 2011 to March 16, 2015
Yaz, from January 1, 2012 to March 16, 2015
All disclosed 535
A-2014-01493 Copies of all Temporary Help Services (THS) contracts awarded from September 1, 2014 to February 28, 2015. Disclosed in part 189
A-2014-01507 All correspondence to and received from Ontario’s Ministry of Health and Long-Term Care with respect to actions taken by Health Canada against Apotex, and Health Canada’ investigations(s) of Apotex and its subsidiaries (June 13, 2014 to Mar. 17, 2015). No records exist 0
A-2014-01510 Adverse Reaction Report (AER) for Lantus (insulin glargine). Report number: E2B_00114944. All disclosed 23
A-2014-01511 Adverse Reaction Report (AER) for Lantus (insulin glargine). Report number: E2B_00124983. Disclosed in part 10
A-2014-01515 Adverse Reaction Report (AER) for Taxotere (docetaxel). Report number: E2B_00112942. Disclosed in part 7
A-2014-01519 Information on the total allocation to Health Canada from the Treasury Board for the Qalipu Mi'kmaq First Nation for 2011, 2012 and 2013 All excluded 0
A-2014-01532 All ProServices contracts issued in the Nation Capital region for the months of October 2014 and November 2014 Disclosed in part 61
A-2014-01538 Adverse Reaction Report (AER) for Eloxatin (oxaliplatin). Report number: 000622292. Disclosed in part 2
A-2014-01540 Adverse Reaction Report (AER) for Eloxatin (oxaliplatin). Report number: E2B_00117955. All disclosed 15
A-2014-01570 Copy of the document related to the “Evaluation of Retailers’ Behaviours Towards Certain Youth Access to Tobacco Restrictions” (MERX Solicitation No. 1000156554), either final or most recent draft. All exempted 0
A-2015-00026 Copies of any evaluation of compliance with tobacco sales to minors laws conducted for Health Canada since January 1, 2013 All exempted 0
A-2015-00051 Copy of contract (#4500318516) deliverables for University of Ottawa. All disclosed 88
A-2015-00053 Copy of contract (#4500306857) deliverables for QMR Consulting (2013 and 2014) Disclosed in part 51
A-2015-00071 Copy of all correspondence received or sent to Minister of Health Rona Ambrose or her offices by current Quebec Minister of Health and Social Services Gaétan Barette. (Feb. 25, 2015, to Apr. 24, 2015) All disclosed 1
A-2015-00080 Information related to the number of briefing notes and other ministerial correspondence created for the Minister, Minister’s Office, Deputy Minister and Assistant Deputy Ministers. (Jan. 1, 2014 to Dec. 31, 2014) All disclosed 19
A-2015-00108 Documents used by Non-Insured Health Benefits and its consultants which provides a definition and/or outlines the criteria of a severe and functionally handicapping malocclusion All disclosed 1
A-2015-00113 Documentation concerning the radon readings taken from the 195 homes in Windsor and Essex County (Ontario) that were used for the “Health Canada report Cross-Canada Survey of Radon Concentrations in Homes – Final Report”, including the locations of these homes identifying high and low readings for radon in the region. Disclosed in part 6
A-2015-00124 Letter issued from Therapeutic Products Directorate to Novopharm Limited (“Novopharm”) certifying that the examination of Dorzolamide was complete. No records exist 0
A-2015-00125 Letter issued prior to January 30, 2006 from Therapeutic Products Directorate to Sandoz Canada Incorporated (“Sandoz”) certifying that the examination of Dorzolamide/Timolol 5 mg/ml and 20 mg/ml was complete. No records exist 0
A-2015-00130 Copies of the following studies :
1. Canadian Health Expenditures Trend and Forecast
2. Hospital Expenditure in Canada
3. Distribution and Characteristics of Physician and their Services
4. Recent Trends in Physician remuneration
5. Drug Expenditure in Canada
6. Mental Health Hospitalizations in Canada highlights 2011
All disclosed 154
A-2015-00131 Copies of the following studies :
1. Explaining Variations in Hospital Expenditures in Canada
2. Explaining Variations in Hospital Expenditures in Canada: an econometric analysis
3. Pharmaceutical Pricing - Fees and Markup Provincial Comparison
4. Projecting Use & Client Affordability of Home Care and Nursing Home 2015-2045
All disclosed 141
A-2015-00132 Adverse Reaction Report (AER). Report number: 000634904. Disclosed in part 3
A-2015-00137 Records related to Commandes Edge Inc. / Edge of Command Inc. of Montreal, Quebec, namely, whether the company is in good standing with Health Canada. No records exist 0
A-2015-00141 Records related to Dramis Network Cabling (N.S.) Limited of Dartmouth, Nova Scotia, namely, whether the company is in good standing with Health Canada. No records exist 0
A-2015-00142 Records related to Dramis Network Cabling (2009) Ltd of Moncton, New Brunswick, namely, whether the company is in good standing with Health Canada No records exist 0
A-2015-00156 Documents on the wisdom and advisability of building a new $1.2 billion hospital on a new site at Station Street and the eventual demolition of the hospital in the West End, impacts on Vancouver residents and emergency services, complete cost breakdown and impacts on Mount St. Joseph’s hospital, Vancouver. (Sep. 1, 2013 to May 26, 2015) No records exist 0
A-2015-00158 Information held by the Human Resources Sector of Health Canada regarding the number of employees who committed suicide. (Jan. 1, 2006, to May 20, 2015) No records exist 0
A-2015-00159 Information held by the Human Resources Sector of Health Canada regarding the number of employees who attempted suicide. (Jan. 1, 2006, to May 20, 2015) No records exist 0
A-2015-00165 Most recent information related to the allowable limits of Lithium in the water, air and soil for the following regions: Regina and area, including Chamberlain, Holdfast and Moosejaw, Saskatchewan. No records exist 0
A-2015-00166 Correspondence between the Minister and the Deputy Minister of Health Canada and the Prince Edward Island (PEI) government regarding the lack of surgical abortions in PEI. (Jan. 2, 2015 to May 29, 2015) All disclosed 2
A-2015-00196 Information related to an environmental assessment of a property located in Brocket, Alberta at various locations and adjacent properties within 100 meters of the site boundary. No records exist 0